KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Activity

94 hedge funds and large institutions have $357M invested in KalVista Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 12 closing their positions.

Holders
94
Holders Change
+3
Holders Change %
+3.3%
% of All Funds
1.63%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
29
Reduced
31
Closed
12
Calls
$9.88M
Puts
–
Net Calls
+$9.88M
Net Calls Change
+$3.89M

Top Buyers

1
DCM
1
Driehaus Capital Management
Illinois
$7.68M
2
Millennium Management
2
Millennium Management
New York
$6.94M
3
IBT
3
International Biotechnology Trust
United Kingdom
$4.59M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$11.3M
5
EAM
5
Eventide Asset Management
Massachusetts
$4.01M

Top Sellers

1
WP
1
Woodline Partners
California
$10.9M
2
PM
2
Prosight Management
Texas
$7.69M
3
SCM
3
Suvretta Capital Management
New York
$24.8M
4
LCM
4
Laurion Capital Management
New York
$5.04M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$1.8M
Name Market Value Shares Shares
Change 		Shares
Change %
DCM
26
DAFNA Capital Management
California
$3.71M 255,313 -10,350 -4%
Northern Trust
27
Northern Trust
Illinois
$3.55M 244,696 +478 +0.2%
Walleye Capital
28
Walleye Capital
New York
$2.16M 148,867 -55,471 -27%
Citadel Advisors
29
Citadel Advisors
Florida
$2.02M 139,522 -33,759 -19%
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
$1.98M 136,194 -7,657 -5%
Renaissance Technologies
31
Renaissance Technologies
New York
$1.8M 124,100 -105,270 -46%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$1.66M 114,622 -9,000 -7%
AAA
33
Affinity Asset Advisors
New York
$1.4M 96,318 +96,318 New
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.39M 95,586 +29,704 +45%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.2M 82,732 +9,597 +13%
Nuveen Asset Management
36
Nuveen Asset Management
Illinois
$1.16M 79,778 +535 +0.7%
NFGH
37
Nan Fung Group Holdings
Hong Kong
$1.14M 78,720 – –
Charles Schwab
38
Charles Schwab
California
$916K 63,116 +217 +0.3%
State of Wisconsin Investment Board
39
State of Wisconsin Investment Board
Wisconsin
$859K 59,229 -15,171 -20%
Point72 Asset Management
40
Point72 Asset Management
Connecticut
$839K 57,800 +57,800 New
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$642K 44,269 -10,707 -19%
BC
42
Birchview Capital
Vermont
$580K 40,000 – –
AC
43
Apogem Capital
New York
$548K 37,784 -24,103 -39%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$544K 37,513 +2,844 +8%
Morgan Stanley
45
Morgan Stanley
New York
$448K 30,882 -28,437 -48%
T. Rowe Price Associates
46
T. Rowe Price Associates
Maryland
$391K 26,946 +5,947 +28%
EW
47
Evoke Wealth
California
$371K 25,583 – –
GCP
48
GSA Capital Partners
United Kingdom
$250K 17,236 -21,414 -55%
AllianceBernstein
49
AllianceBernstein
Tennessee
$248K 17,064 +1,964 +13%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$244K 16,819 +64 +0.4%
1
2
3 4 5